Where is Pharm3r located?

Pharm3r is headquartered in New York City, United States.

How many employees does Pharm3r have?

As of Apr 30, 2026, the latest employee count at Pharm3r is 9.

Is Pharm3r a funded company?

Pharm3r is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Pharm3r rank among its competitors?

Pharm3r ranks 55th amongst 173 active competitors, of which 22 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Novotech, which secured an undisclosed amount in Mar, 2025.

Who are the top competitors of Pharm3r?

Pharm3r's top competitors include Owkin, Novotech and mPulse. Among them, Novotech secured the most recent funding round in March, 2025.

Pharm3r - 2026 Company Profile, Team & Competitors

Pharm3r is an unfunded company based in New York City (United States), founded in 2011 by Libbe Englander. It operates as a Life science data insights to uncover risks and drive confident decisions. Pharm3r has not raised any funding yet. The company has 173 active competitors, including 22 funded and 29 that have exited. Its top competitors include companies like Owkin, Novotech and mPulse.

Company Details

Life science data insights to uncover risks and drive confident decisions. The company provides refined life science data insights to insurance, legal, financial, pharmaceutical, and medical device companies. They offer an information platform that analyzes relevant datasets, verifies data, and augments findings with industry expert analysis to deliver precise and actionable insights. Their focused expertise covers drugs & medical devices, facilities & supply chains, adverse events & patient outcomes, regulatory & litigation, and clinical trials. They blend data science with human expertise to illuminate future possibilities in the world of life sciences, empowering smarter healthcare decisions through post-market surveillance, supply chain monitoring, and market intelligence. This is a B2B, SaaS company.

Website: pharm3r.com
Social
Email ID: *****@pharm3r.com, *****@pharm3r.com
Phone Number: +1 **********

Key Metrics

Founded Year

2011

Location

New York City, United States

Stage

Unfunded

Ranked

55^th among 173 active competitors

Employee Count

9 as on Apr 30, 2026

Similar Companies

Owkin & 204 more

View Pharm3r's full profile

Pharm3r has not raised any funding rounds yet.

The founders of Pharm3r is Libbe Englander.

Here are the details of Pharm3r's key team members:

Libbe Englander: Co-Founder & CEO of Pharm3r.

View details of Pharm3r's Founder profiles and Board Members

Pharm3r's employee count trend

Pharm3r has 9 employees as of Apr 26. Here is Pharm3r's employee count trend over the years:

Uncover Pharm3r's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Pharm3r include Owkin, Novotech and mPulse. Here is the list of Top 10 competitors of Pharm3r, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Owkin 2016, Paris (France), Series B	Developer of agentic AI platform for biomedical research and drug development	$321M	F-Prime Capital, Otium Capital & 18 others	71/100
2nd	Novotech 2002, Sydney (Australia), Acquired	Provider of clinical research services across all trial phases and therapeutic areas	$255M	Mubadala, GIC & 4 others	68/100
3rd	mPulse 2014, Los Angeles (United States), Series C	Digital engagement and analytic solutions for healthcare payers	$41.7M	Optum Ventures, OCA Ventures & 13 others	66/100
4th	Dotmatics 2005, Bishop s Stortford (United Kingdom), Acquired	AI powered scientific data management and workflow automation solutions	$11.3M	Scottish Equity Partners, Insight Partners ... & 4 others	65/100
5th	Concert AI 2018, Boston (United States), Series C	Provider of AI and real-world data solutions for life sciences	$300M	Sixth Street, Declaration Partners & 3 others	63/100
6th	Bioptimus 2024, Paris (France), Series A	Developer of AI foundation model to transform biological research	$76M	Cathay Innovation, Bpifrance & 15 others	60/100
7th	Digital Science 2010, London (United Kingdom), Funding Raised	Research assistance software solutions	-	HHS	59/100
8th	Doctor Evidence 2004, Santa Monica (United States), Acquired	Evidence based medical decision solutions for multiple healthcare stakeholders	$1.5M	Wormhole Capital, Costella Kirsch	56/100
9th	Sygnature Discovery 2004, Nottingham (United Kingdom), Series A	Provider of services and products for integrated drug discovery	-	Rothschild & Co, Torreal & 4 others	56/100
10th	Instem 1969, Conshohocken (United States), Acquired	Software solutions for data collection, management, and analysis for the life science industry	-	Eiffel Investment Group, Europa & 1 others	55/100
55th	Pharm3r 2011, New York City (United States), Unfunded	Life science data insights to uncover risks and drive confident decisions	-	-	32/100